🇺🇸 FDA
Patent

US 11013803

Near infrared photoimmunotherapy (NIR-PIT) of suppressor cells to treat cancer

granted A61KA61K2039/505A61K41/0038

Quick answer

US patent 11013803 (Near infrared photoimmunotherapy (NIR-PIT) of suppressor cells to treat cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/505, A61K41/0038, A61K47/6803, A61K47/6849